Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry, v3.5.4, replacing the previous v3.5.3. This reflects a small update to the page's revision metadata rather than any change to the study content.
    Difference
    0.1%
    Check dated 2026-05-19T10:25:33.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The Record History now lists Revision: v3.5.3, replacing the previous Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-27T19:52:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the history.
    Difference
    0.1%
    Check dated 2026-04-20T15:46:45.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.0' has been added to the history. The entry for 'Revision: v3.4.3' has been removed.
    Difference
    0.1%
    Check dated 2026-03-22T21:37:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.3 and no longer displays Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-08T12:24:22.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Revision history updated: added entry v3.4.2 and removed entry v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T14:42:46.000Z thumbnail image

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.